-
Companies with NDRs 5/20
-
Companies with NDRs 5/19
-
Companies with NDRs 5/18
-
Roth Capital Transfers Coverage on Cyclacel Pharmaceuticals (CYCC) at Buy
-
Cyclacel Announces Closing of $20 Million Public Offering
-
Cyclacel Pharma (CYCC) Prices $20M Offering of Common Stock, Warrants
-
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
-
Roth Capital Transfers Coverage on Cyclacel Pharmaceuticals (CYCC) at Buy
-
Cyclacel to Participate in 31st Annual ROTH Conference March 18-19
-
Cyclacel to Participate in 31st Annual ROTH Conference March 18-19
-
Roth Capital Starts Cyclacel Pharmaceuticals (CYCC) at Buy
-
Morning Movers 09/12: (GLBL) (NETL) (MFW) (RXII) Higher; (SPEX) (CFX) (CYCC) (CTCM) Lower
-
Roth Capital Downgrades Cyclacel Pharmaceuticals (CYCC) to Neutral
-
Cyclacel Pharma (CYCC) Announces $22.1M Unit Offering to Institutional Investors
-
Unusual 11 Mid-Day Movers 2/4: HDNG, AFFX, CYCC, DCTH, EDZ Higher; LAD, DBTK, MWW, SPR Lower
-
Notable Analyst Rating Changes of the Day 02/04: V, AKAM, LCC, BRCM Upgraded; WU, VZ, MWW, AVNW, RBS, EDMC Downgraded
-
Morning Movers 2/4: HDNG, AFFX, UHAL, CYCC, OTEX, OPNT Higher; DBTK, LAD, MWW, MSTR, SPR, WFR Lower
-
Cyclacel Pharma (CYCC): Initiated Buy and $7 target at Roth Capital - 2010 Pivotal for CYCC
-
Roth Capital Initiates Coverage on Cyclacel Pharmaceuticals (CYCC) with a Buy
-
Cyclacel Pharma (CYCC) Announces Registered Direct Offering, to Raise Proceeds of $7.9M
-
Cyclacel Pharma (CYCC) Enters Agreement to Raise $9.5M in Gross Proceeds from Direct Offering
-
Morning Movers 01/08: AEN, CYCC, SPDE, LEI, HTX, LUNA Higher; SNTA, ROG, DMAN, LWSN Lower

